Gene · 3984
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PAK2 promotes proliferation, migration, and invasion of lung squamous cell carcinoma through the LIMK1/cofilin signaling pathway. | J Biomed Res | 2024 | 38828848 | PubTator, text mining | PubMed |
| RABV induces biphasic actin cytoskeletal rearrangement through Rac1 activity modulation. | J Virol | 2024 | 38809020 | PubTator, text mining | PubMed |
| TAZ is involved in breast cancer cell migration via regulating actin dynamics. | Front Oncol | 2024 | 38774409 | PubTator, text mining | PubMed |
| PCDH17 restricts dendritic spine morphogenesis by regulating ROCK2-dependent control of the actin cytoskeleton, modulating emotional behavior. | Zool Res | 2024 | 38747058 | PubTator, text mining | PubMed |
| Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization. | Eur J Med Chem | 2024 | 38669909 | PubTator, text mining | PubMed |
| Systematic identification and characterization of exon-intron circRNAs. | Genome Res | 2024 | 38609186 | PubTator, text mining | PubMed |
| PAK1-Dependent Regulation of Microtubule Organization and Spindle Migration Is Essential for the Metaphase I-Metaphase II Transition in Porcine Oocytes. | Biomolecules | 2024 | 38397472 | PubTator, text mining | PubMed |
| Myocardial fibrosis induced by nonylphenol and its regulatory effect on the TGF-β1/LIMK1 signaling pathway. | Ecotoxicol Environ Saf | 2024 | 38364763 | PubTator, text mining | PubMed |
| An essential role for the RNA helicase DDX6 in NMDA receptor-dependent gene silencing and dendritic spine shrinkage. | Sci Rep | 2024 | 38321143 | PubTator, text mining | PubMed |
| Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer. | BMC Complement Med Ther | 2024 | 38303001 | PubTator, text mining | PubMed |
| Alternative splicing and related RNA binding proteins in human health and disease. | Signal Transduct Target Ther | 2024 | 38302461 | PubTator, text mining | PubMed |
| 14-3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer. | Cell Commun Signal | 2024 | 38279176 | PubTator, text mining | PubMed |
| The Role of Rho Kinase Inhibitors in Corneal Diseases. | Drug Des Devel Ther | 2024 | 38264539 | PubTator, text mining | PubMed |
| Cofilin Inhibitor Improves Neurological and Cognitive Functions after Intracerebral Hemorrhage by Suppressing Endoplasmic Reticulum Stress Related-Neuroinflammation. | Pharmaceuticals (Basel) | 2024 | 38256947 | PubTator, text mining | PubMed |
| The Multifaceted Role of Cofilin in Neurodegeneration and Stroke: Insights into Pathogenesis and Targeting as a Therapy. | Cells | 2024 | 38247879 | PubTator, text mining | PubMed |
| Towards Understanding the Development of Breast Cancer: The Role of RhoJ in the Obesity Microenvironment. | Cells | 2024 | 38247865 | PubTator, text mining | PubMed |
| Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes. | Sci Rep | 2024 | 38238555 | PubTator, text mining | PubMed |
| TBC1D1 represses glioma progression by altering the integrity of the cytoskeleton. | Aging (Albany NY) | 2024 | 38189823 | PubTator, text mining | PubMed |
| DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. | Nat Commun | 2024 | 38177131 | PubTator, text mining | PubMed |
| MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer. | Int J Biol Sci | 2024 | 38164185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3984/papers?page=7